ArriVent BioPharma (AVBP) Net Equity Issued and Repurchased (2023 - 2026)
ArriVent BioPharma (AVBP) recorded Net Equity Issued and Repurchased of $85.24 million in Q2 2026, up 13.1% from $75.34 million a year earlier and up 55.8% from the prior quarter.
Powered by 
Analysis
ArriVent BioPharma (AVBP) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends
On a TTM basis, ArriVent BioPharma's Net Equity Issued and Repurchased came in at $260.73 million as of Jun 30, 2026, down 2.6% year-over-year; for FY2025, it was $202.63 million, up 9.0% from FY2024.
- Across earlier years, Net Equity Issued and Repurchased came in at $185.95 million in FY2024 (+314.0%) and $44.92 million in FY2023.
- Quarterly Net Equity Issued and Repurchased has ranged from -$24,000 in Q2 2023 to $185.91 million in Q3 2024 over the past five years.
- Per Business Quant, the preceding three quarters came in at $54.72 million (Q1 2026), $34.66 million (Q4 2025) and $86.12 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | ArriVent BioPharma | 1.46 Bn | 1.46 Bn | - | 85.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 85.24 Mn |
| Mar 31, 2026 | 54.72 Mn |
| Dec 31, 2025 | 34.66 Mn |
| Sep 30, 2025 | 86.12 Mn |
| Jun 30, 2025 | 75.34 Mn |
| Mar 31, 2025 | 6.52 Mn |
| Sep 30, 2024 | 185.91 Mn |
| Jun 30, 2024 | 44,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Jun 30, 2023 | -24,000.00 |
| Mar 31, 2023 | 44.94 Mn |
API Access
ArriVent BioPharma Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=AVBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "AVBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=AVBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();